Target |
Mechanism RARα agonists [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date26 Jul 2021 |
Mechanism GR agonists [+4] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date25 Apr 2019 |
Target |
Mechanism GR agonists [+3] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date27 Mar 2015 |
Start Date01 Mar 2024 |
Sponsor / Collaborator |
Start Date05 Dec 2023 |
Sponsor / Collaborator- |
Start Date31 Oct 2023 |
Sponsor / Collaborator |